Duration of Hormone Replacement Therapy, Breast Tumour Size and Grade in a Screening Programme
โ Scribed by Dorota M Gertig; Bircan Erbas; Ashley Fletcher; Alison Amos; Anne M Kavanagh
- Book ID
- 111546559
- Publisher
- Springer US
- Year
- 2003
- Tongue
- English
- Weight
- 75 KB
- Volume
- 80
- Category
- Article
- ISSN
- 0167-6806
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
Exposure to hormone-replacement therapy (HRT) has consistently been associated with an increased incidence of breast cancer, particularly of small tumours. Other tumour characteristics in relation to HRT have received less scientific attention. Our aim in this population-based prospective cohort stu
There is concern that hormone replacement therapy (HRT) increases the risk of breast cancer. We undertook a casecontrol study of this risk relationship within a cohort of 40-to 74-year-old women in Uppsala County, Sweden, who participated in mammography screening. Incident cases of breast cancer wer
## Abstract ## BACKGROUND Observational studies and randomized trials have demonstrated that hormone replacement therapy (HRT) increases the recipient's risk of developing breast carcinoma. Because it is known that some breast malignancies are hormonally responsive and that others are not, it has
## Abstract We report the case of a 78โyearโold woman who had been receiving hormoneโreplacement therapy (HRT) for 6 years and had a 4โmonth history of a painless nodule in the 9 o'clock position in her right breast. Mammography performed 4 years previously had shown a 4โmm bilobed, ovoid, wellโdef